Profil
Clarence L.
Dellio served as Vice President-Manufacturing at Becton, Dickinson & Co. He then worked as Chief Operating Officer & Senior Vice President at XOMA Corp.
from 1984 to 2004.
From 2004 to 2008, he was the President & Chief Operating Officer at Neosil, Inc. In 2011 to 2013, he served as Chief Operating Officer at Aevi Genomic Medicine, Inc. Mr. Dellio obtained his undergraduate degree from Bentley University.
Anciens postes connus de Clarence L. Dellio
| Sociétés | Poste | Fin |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Directeur des opérations | 31/12/2013 |
Neosil, Inc.
Neosil, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | President | - |
| XOMA ROYALTY CORPORATION | Directeur des opérations | 01/01/2004 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - |
Formation de Clarence L. Dellio
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Neosil, Inc.
Neosil, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aevi Genomic Medicine, Inc.
Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
















